OTC: NPNKF - Nippon Shinyaku Co., Ltd.

Yield per half year: 0%
Dividend yield: +212.23%
Sector: Healthcare

Nippon Shinyaku Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
21.46 31.52 -31.89% 16.03 +33.88%
P/S 3.4 3.23 5.15%
P/BV 2.5 3.36 -25.61%
P/FCF 0 21.22 -100%
Ev/Ebitda 12.12 9.93 22.07%
Ev/S 3 1.88 59.13%
Ev/FCF 29.95 19.91 50.41%
E/P 0 1.47 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
24.74 24.7 0.1502% 24.79 -0.231%
ROE 11.66 13.11 -11.09%
ROA 9.61 6.09 57.61%
ROIC 0 15.56 -100%
ROS 15.82 12.44 27.21%
ROCE 15.63 15.21 2.74%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0749 6.21 -98.8% 0.0779 -3.91%
Nеt Debt/Ebitda -1.61 -5.72 -71.88%
Debt/Ratio 0.0112 0.213 -94.72%
Debt/Equity 0.000712 12.49 -99.99%
Debt/Net Income 0.117 15.07 -99.22%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
212.23 1.76 11948.56% 125.39 +69.26%
Number of years of dividend growth 8 1.21 560.47%
DSI 0.9286 0.7783 19.3%
Average dividend growth -2159.03 -269.81 700.2%
Average percentage for 5 years 125.39 2.8 4372.29%
Average percentage for payments 29.09 246.95 -88.22%
Difference from average difference in sector 210.47

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-98.94 132.71 -174.55%
Growth impulse Ebitda in 5 years -98.79 100.7 -198.1%
Growth impulse Net Income in 5 years -98.82 116.53 -184.8%
Growth impulse FCF in 5 years -99.12 88.28 -212.28%
Growth impulse EPS in 5 years -98.82 217.84 -145.36%
IP Score
5.65/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription